Both Short- and Long-term Outcome Differences According to Patient Frailty

Frailty Clinical Trial

Official title:

Both Short- and Long-term Outcome Differences According to Patient Frailty

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05257226
• Other study ID #: Bos study
• Status: Recruiting
• Start date: January 1, 2019
• Est. completion date: December 31, 2030

Study information

• Verified date: February 2022
• Source: Kochi University
• Contact: Takehiro Okabayashi
• Phone: +81- 88-837-3000
• Email: tokabaya[@]gmail.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The evaluation for cancer treatment successful has been used by overall survival rate and/or postoperative complications, especially surgical area. Now postoperative QOL has been more importantly required. Therefore this study was conduced to investigate the association between postoperative outcomes and patients frailty.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: December 31, 2030
• Est. primary completion date: January 31, 2025
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• surgical patients

Exclusion Criteria:

• a body weight loss of >10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Related Conditions & MeSH terms

• Frailty

Intervention

Behavioral:
• frailty
questionaire

Locations

Country	Name	City	State
Japan	Takehiro Okabayashi	Kochi

Sponsors (1)

Lead Sponsor	Collaborator
Kochi University

Country where clinical trial is conducted

Japan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative short-term outcomes	postoperative complications	up to 24 weeks
Secondary	postoperative long-term outcomes	survival rate	5 year